EP 3978501 A1 20220406 - TETRACYCLIC COMPOUNDS AS CDC7 INHIBITORS
Title (en)
TETRACYCLIC COMPOUNDS AS CDC7 INHIBITORS
Title (de)
TETRACYCLISCHE VERBINDUNGEN ALS CDC7-INHIBITOREN
Title (fr)
COMPOSÉS TÉTRACYCLIQUES AGISSANT EN TANT QU'INHIBITEURS DE CDC7
Publication
Application
Priority
- CN 201910464384 A 20190530
- CN 201910491339 A 20190606
- CN 201911128459 A 20191118
- CN 2020093480 W 20200529
Abstract (en)
A new class of tetracyclic compounds acting as Cdc7 inhibitors; specifically disclosed are a compound represented by formula (I), isomers thereof, or pharmaceutically acceptable salts thereof.
IPC 8 full level
C07D 495/04 (2006.01); A61K 31/519 (2006.01); A61P 35/00 (2006.01); C07D 519/00 (2006.01)
CPC (source: CN EP IL KR US)
A61K 31/519 (2013.01 - IL KR); A61P 35/00 (2018.01 - CN EP IL KR); C07D 495/04 (2013.01 - EP IL); C07D 495/14 (2013.01 - CN KR US); C07D 519/00 (2013.01 - CN IL US); C07B 2200/07 (2013.01 - CN); C07D 495/14 (2013.01 - EP); C07D 519/00 (2013.01 - EP)
Designated contracting state (EPC)
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated extension state (EPC)
BA ME
DOCDB simple family (publication)
EP 3978501 A1 20220406; EP 3978501 A4 20230524; AU 2020281411 A1 20220106; BR 112021023886 A2 20220118; CA 3142202 A1 20201203; CN 113874379 A 20211231; CN 113874379 B 20230331; CN 116425770 A 20230714; IL 288472 A 20220101; JP 2022534316 A 20220728; KR 20220027883 A 20220308; MX 2021014629 A 20220223; SG 11202113212Y A 20211230; US 2022235068 A1 20220728; WO 2020239107 A1 20201203
DOCDB simple family (application)
EP 20813107 A 20200529; AU 2020281411 A 20200529; BR 112021023886 A 20200529; CA 3142202 A 20200529; CN 2020093480 W 20200529; CN 202080039204 A 20200529; CN 202310266535 A 20200529; IL 28847221 A 20211128; JP 2021571374 A 20200529; KR 20217043231 A 20200529; MX 2021014629 A 20200529; SG 11202113212Y A 20200529; US 202017595869 A 20200529